• Patient Action Center
  • Seniors Rising Now
0 Items
Patients Rising Now
  • Home
  • About
    • About Us
    • Who We Are
    • Partners and Coalitions
    • Corporate Membership
    • Corporate Members
    • Financials
  • Issues
    • 117th Congress Advocacy Scorecard
    • Legislative Positions
    • Terry’s Hot Take
    • News and Insights
    • Positions
    • Policy Supported
  • Take Action
    • Patient Action Center
    • What You Can Do
    • Advocacy Masterclass
  • Donate
Select Page
  • Home
  • About
    • About Us
    • Who We Are
    • Partners and Coalitions
    • Corporate Membership
    • Corporate Members
    • Financials
  • Issues
    • 117th Congress Advocacy Scorecard
    • Legislative Positions
    • Terry’s Hot Take
    • News and Insights
    • Positions
    • Policy Supported
  • Take Action
    • Patient Action Center
    • What You Can Do
    • Advocacy Masterclass
  • Donate

Tag: Rare Disease

A Mutistakeholder Approach to Rare Disease Drug Development 

A Mutistakeholder Approach to Rare Disease Drug Development 

Oct 31, 2022 | Access, Featured

Surabhi Dangi-Garimella, Ph.D. A rare disease, by the U.S. definition, is one that afflicts less than 200,000 individuals in the population at a given time. Compared to more widespread conditions such as heart disease and diabetes, ‘rare’ diseases do not receive as...
Read more
Patients Rising Now Calls on Lawmakers to Create Federal Rare Disease Program

Patients Rising Now Calls on Lawmakers to Create Federal Rare Disease Program

Jul 20, 2022 | Featured, Letters Submitted

We sent a letter to members of the House and Senate Appropriations Committees regarding FY23 funding. The House bills that fund HHS and FDA both established double digit percentage increases in funding; we thanked House lawmakers for their continued support of these...
Read more
Season 3 | Episode 8: Speedy Rare Disease Drug Reviews

Season 3 | Episode 8: Speedy Rare Disease Drug Reviews

Feb 28, 2022 | Featured, Federal Issues

On this episode of the podcast, Terry and Bob discuss accelerated drug review for rare diseases. This topic coincides with Rare Disease Day on February 28. With the Prescription Drug User Fee Act (PDUFA) up for renewal in Congress, much is at stake for the rare...
Read more
S2 | E 41: Chronic Disease + the Next Pandemic with Scott Gottlieb

S2 | E 41: Chronic Disease + the Next Pandemic with Scott Gottlieb

Oct 17, 2021 | COVID-19, Featured, Podcast, Uncategorized

On this episode of the podcast, Terry and Bob discuss how the country can better prepare for the next pandemic. Better preparation is especially necessary for those with rare and chronic diseases who are most vulnerable. They discuss pending legislation to make prior...
Read more
S2 | E39: Patient How-To Guide: Health Policy Advocacy

S2 | E39: Patient How-To Guide: Health Policy Advocacy

Oct 3, 2021 | Featured, Federal Issues, Health Policy

On this episode of the podcast, Terry and Bob discuss the latest in Congress and what it means for patients. They highlight the two spending bills Democrats are trying to pass and the implications on those with rare diseases, whom they argue deserves a seat at the...
Read more
« Older Entries

Categories

  • Access
  • Advocacy
  • California
  • Comment Letters
  • Copay Accumulators
  • Copay Assistance
  • COVID-19
  • Drug Costs
  • FDA
  • Featured
  • Featured Action
  • Federal Issues
  • Health Insurance
  • Health Policy
  • ICER
  • Illinois
  • Issues
  • Letters Submitted
  • Letters Supported
  • Massachusetts
  • Medicaid
  • Medicare
  • Medicare Part D
  • News
  • Op-Ed
  • Out of Pocket Costs
  • Pharmacy Benefit Managers
  • Podcast
  • Prescription Drugs
  • Press Releases
  • Public Statement
  • QALY
  • State Issues
  • Statements
  • Step Therapy
  • Surprise Billing
  • Terry's Hot Take
  • Uncategorized
  • Value Based Insurance Design
  • Value Frameworks
  • Virtual Advocacy Chat

Tags

21st Century Cures Act 340B Access to Care Advocacy Alzheimer's Biden Administration biosimilars Cancer cms Copay Accumulators copay assistance COVID-19 Vaccine drug costs Drug Manufacturing Drug Pricing drug rebate fail first FDA Gene Therapies H.R.3 Health Insurance hospital bills HR 3708 hsa ICER Insurance design Joe Biden medicare Part B medicare part D Mental Health Nonmedical Switching open enrollment Out of Pocket Costs PBM PBMs pharmacy benefit managers Price Transparency Prior Authorization QALY Rare Disease Right to Repair Step Therapy Telehealth transparency Value Framework

Recent Posts

  • Rural Hospital Closures Further Complicates Healthcare Access in Mississippi
  • Contract Changes Leave DoD TRICARE Beneficiaries Without Pharmacy Access
  • Most Popular Podcast Episodes in 2022 From Patients Rising
  • Patients Rising Now Signs onto Letter to President on Alzheimer’s Scans
  • PRN and 17 Patient Groups Send Letter to Hill on Home Health Cuts

Get Updates In Your Inbox

Sign up for updates about our patient education, support and advocacy programs and initiatives.

YES, KEEP ME UPDATED

Patients Rising Now

We are a 501c4 group dedicated to demanding transparency in health care.  We are part of the Patients Rising suite of programs and services.

700 12th St. NW 700, Suite 700
Washington, DC 20005
202-679-8223

 

  • Privacy Policy
  • Sponsor Opportunities
  • Patients Rising
  • Patient Action Center
  • Facebook
  • Twitter
  • Instagram
All rights reserved. © 2023 Patients Rising Now